Victor Levitsky

2.1k total citations
37 papers, 1.5k citations indexed

About

Victor Levitsky is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Victor Levitsky has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Victor Levitsky's work include Immune Cell Function and Interaction (18 papers), Immunotherapy and Immune Responses (17 papers) and T-cell and B-cell Immunology (11 papers). Victor Levitsky is often cited by papers focused on Immune Cell Function and Interaction (18 papers), Immunotherapy and Immune Responses (17 papers) and T-cell and B-cell Immunology (11 papers). Victor Levitsky collaborates with scholars based in Sweden, United States and Switzerland. Victor Levitsky's co-authors include Maria G. Masucci, Jelena Levitskaya, Rolf Kiessling, Michael Uhlin, Teresa Frisan, Håkan Norell, Ida Rasmusson, Katarina Le Blanc, Alessandro Moretta and Hodjattallah Rabbani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Immunity.

In The Last Decade

Victor Levitsky

36 papers receiving 1.5k citations

Peers

Victor Levitsky
Hong Qin United States
John O. Richards United States
Elin Hub United Kingdom
H. J. Ree United States
Victor Levitsky
Citations per year, relative to Victor Levitsky Victor Levitsky (= 1×) peers Mahyar Nouri‐Shirazi

Countries citing papers authored by Victor Levitsky

Since Specialization
Citations

This map shows the geographic impact of Victor Levitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Levitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Levitsky more than expected).

Fields of papers citing papers by Victor Levitsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Levitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Levitsky. The network helps show where Victor Levitsky may publish in the future.

Co-authorship network of co-authors of Victor Levitsky

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Levitsky. A scholar is included among the top collaborators of Victor Levitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Levitsky. Victor Levitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levitsky, Victor, Eike Hoffmann, Guy Georges, et al.. (2015). Committing Cytomegalovirus-Specific CD8 T Cells to Eliminate Tumor Cells by Bifunctional Major Histocompatibility Class I Antibody Fusion Molecules. Cancer Immunology Research. 3(7). 764–776. 17 indexed citations
2.
Thommen, Daniela S., Jens Schreiner, Philipp Müller, et al.. (2015). Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors. Cancer Immunology Research. 3(12). 1344–1355. 315 indexed citations
3.
Schreiner, Jens, Daniela S. Thommen, Petra Herzig, et al.. (2015). Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor. OncoImmunology. 5(2). e1062969–e1062969. 28 indexed citations
4.
Stikvoort, Arwen, Lars Egevad, Lars Henningsohn, et al.. (2014). Novel method to characterize immune cells from human prostate tissue. The Prostate. 74(14). 1391–1399. 10 indexed citations
5.
Hallermalm, Kristian, Bruce Motyka, R. Chris Bleackley, et al.. (2008). Modulation of the Tumor Cell Phenotype by IFN-γ Results in Resistance of Uveal Melanoma Cells to Granule-Mediated Lysis by Cytotoxic Lymphocytes. The Journal of Immunology. 180(6). 3766–3774. 40 indexed citations
6.
Pavlenko, Maxim, Christoph Leder, Sonia Carreño-Moreno, Victor Levitsky, & Pavel Pisa. (2007). Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice. Vaccine. 25(34). 6341–6347. 16 indexed citations
7.
Kiessling, Rolf, et al.. (2006). Cytotoxic T Lymphocytes Induce Caspase-Dependent and -Independent Cell Death in Neuroblastomas in a MHC-Nonrestricted Fashion. The Journal of Immunology. 177(11). 7540–7550. 7 indexed citations
8.
Sandalova, Elena, Andrew D. Hislop, & Victor Levitsky. (2006). T-Cell Receptor Triggering Differentially Regulates Bim Expression in Human Lymphocytes From Healthy Individuals and Patients With Infectious Mononucleosis. Human Immunology. 67(12). 958–965. 3 indexed citations
9.
Vertuani, Simona, et al.. (2006). Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells. Cancer Immunology Immunotherapy. 56(2). 193–204. 16 indexed citations
10.
Uhlin, Michael, Maria G. Masucci, & Victor Levitsky. (2006). Is the Activity of Partially Agonistic MHC:Peptide Ligands Dependent on the Quality of Immunological Help?. Scandinavian Journal of Immunology. 64(6). 581–587. 6 indexed citations
11.
Uhlin, Michael, Elena Sandalova, Maria G. Masucci, & Victor Levitsky. (2005). Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes. European Journal of Immunology. 35(10). 2929–2939. 6 indexed citations
12.
Sandalova, Elena, Cheng‐Hong Wei, Maria G. Masucci, & Victor Levitsky. (2004). Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering. Proceedings of the National Academy of Sciences. 101(9). 3011–3016. 65 indexed citations
13.
Vertuani, Simona, et al.. (2003). Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.. PubMed. 63(22). 8006–13. 28 indexed citations
14.
15.
Malmberg, Karl‐Johan, Victor Levitsky, Håkan Norell, et al.. (2002). IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. Journal of Clinical Investigation. 110(10). 1515–1523. 159 indexed citations
16.
Achour, Adnane, Jakob Michaëlsson, Robert A. Harris, et al.. (2002). A Structural Basis for LCMV Immune Evasion. Immunity. 17(6). 757–768. 48 indexed citations
17.
Wei, Cheng‐Hong, Hideo Yagita∥, Maria G. Masucci, & Victor Levitsky. (2001). Different Programs of Activation-Induced Cell Death Are Triggered in Mature Activated CTL by Immunogenic and Partially Agonistic Peptide Ligands. The Journal of Immunology. 166(2). 989–995. 15 indexed citations
18.
Rottenberg, Martı́n E., Antonio Gigliotti Rothfuchs, Dulceaydee Gigliotti, et al.. (2000). Regulation and Role of IFN-γ in the Innate Resistance to Infection with Chlamydia   pneumoniae. The Journal of Immunology. 164(9). 4812–4818. 113 indexed citations
19.
Frisan, Teresa, Victor Levitsky, & Maria G. Masucci. (2000). Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B cells. International Journal of Cancer. 88(6). 881–888. 32 indexed citations
20.
Levitsky, Victor, Pedro O. de Campos‐Lima, Teresa Frisan, & Maria G. Masucci. (1998). The Clonal Composition of a Peptide-Specific Oligoclonal CTL Repertoire Selected in Response to Persistent EBV Infection Is Stable Over Time. The Journal of Immunology. 161(2). 594–601. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026